<?xml version="1.0" ?>
<document id="3a2f058d14f4b6db1e7191a2ed2634d5c5699455">
  <chunk id="3a2f058d14f4b6db1e7191a2ed2634d5c5699455.c0" text="Essential role of HCMV deubiquitinase in promoting oncogenesis by targeting anti-viral innate immune signaling pathways">
    <entity charOffset="10-14" id="3a2f058d14f4b6db1e7191a2ed2634d5c5699455.c0.e0" ontology_id="CHEBI_50906" text="role" type="chemical"/>
  </chunk>
  <chunk id="3a2f058d14f4b6db1e7191a2ed2634d5c5699455.c1" text="Cancer is a multifactorial disease and virus-mediated carcinogenesis is one of the crucial factors, which is poorly understood. Human cytomegalovirus (HCMV) is a herpesvirus and its components have been evidenced to be associated with cancer of different tissue origin. However, its role in cancer remains unknown. Here, we identified a conserved herpesviral tegument protein known as pUL48 of HCMV, encoding deubiquitinase enzyme, as having a key role in carcinogenesis. We show using deubiquitinase sufficient-and deficient-HCMV that HCMV deubiquitinase is a key in inducing enhanced cellular metabolic activity through upregulation of several anti-apoptotic genes and downregulation of several pro-apoptotic genes expression. Furthermore, HCMV deubiquitinase acquires pro-tumor functions by inhibiting PRR-mediated type I interferon via deubiquitination of TRAF6, TRAF3, IRAK1, IRF7 and STING. Taken together, our results suggest that HCMV infection may promote oncogenesis by inhibiting innate immunity of the host.">
    <entity charOffset="0-6" id="3a2f058d14f4b6db1e7191a2ed2634d5c5699455.c1.e0" ontology_id="DOID_162" text="Cancer" type="disease"/>
    <entity charOffset="27-34" id="3a2f058d14f4b6db1e7191a2ed2634d5c5699455.c1.e1" ontology_id="DOID_4" text="disease" type="disease"/>
    <entity charOffset="235-241" id="3a2f058d14f4b6db1e7191a2ed2634d5c5699455.c1.e2" ontology_id="DOID_162" text="cancer" type="disease"/>
    <entity charOffset="283-287" id="3a2f058d14f4b6db1e7191a2ed2634d5c5699455.c1.e3" ontology_id="CHEBI_50906" text="role" type="chemical"/>
    <entity charOffset="291-297" id="3a2f058d14f4b6db1e7191a2ed2634d5c5699455.c1.e4" ontology_id="DOID_162" text="cancer" type="disease"/>
    <entity charOffset="368-375" id="3a2f058d14f4b6db1e7191a2ed2634d5c5699455.c1.e5" ontology_id="CHEBI_16541" text="protein" type="chemical"/>
    <entity charOffset="448-452" id="3a2f058d14f4b6db1e7191a2ed2634d5c5699455.c1.e6" ontology_id="CHEBI_50906" text="role" type="chemical"/>
    <entity charOffset="825-835" id="3a2f058d14f4b6db1e7191a2ed2634d5c5699455.c1.e7" ontology_id="CHEBI_52999" text="interferon" type="chemical"/>
    <pair e1="3a2f058d14f4b6db1e7191a2ed2634d5c5699455.c1.e0" e2="3a2f058d14f4b6db1e7191a2ed2634d5c5699455.c1.e3" id="3a2f058d14f4b6db1e7191a2ed2634d5c5699455.c1.p0" relation="true"/>
    <pair e1="3a2f058d14f4b6db1e7191a2ed2634d5c5699455.c1.e0" e2="3a2f058d14f4b6db1e7191a2ed2634d5c5699455.c1.e5" id="3a2f058d14f4b6db1e7191a2ed2634d5c5699455.c1.p1" relation="true"/>
    <pair e1="3a2f058d14f4b6db1e7191a2ed2634d5c5699455.c1.e0" e2="3a2f058d14f4b6db1e7191a2ed2634d5c5699455.c1.e6" id="3a2f058d14f4b6db1e7191a2ed2634d5c5699455.c1.p2" relation="true"/>
    <pair e1="3a2f058d14f4b6db1e7191a2ed2634d5c5699455.c1.e0" e2="3a2f058d14f4b6db1e7191a2ed2634d5c5699455.c1.e7" id="3a2f058d14f4b6db1e7191a2ed2634d5c5699455.c1.p3" relation="true"/>
    <pair e1="3a2f058d14f4b6db1e7191a2ed2634d5c5699455.c1.e1" e2="3a2f058d14f4b6db1e7191a2ed2634d5c5699455.c1.e3" id="3a2f058d14f4b6db1e7191a2ed2634d5c5699455.c1.p4" relation="true"/>
    <pair e1="3a2f058d14f4b6db1e7191a2ed2634d5c5699455.c1.e1" e2="3a2f058d14f4b6db1e7191a2ed2634d5c5699455.c1.e5" id="3a2f058d14f4b6db1e7191a2ed2634d5c5699455.c1.p5" relation="true"/>
    <pair e1="3a2f058d14f4b6db1e7191a2ed2634d5c5699455.c1.e1" e2="3a2f058d14f4b6db1e7191a2ed2634d5c5699455.c1.e6" id="3a2f058d14f4b6db1e7191a2ed2634d5c5699455.c1.p6" relation="true"/>
    <pair e1="3a2f058d14f4b6db1e7191a2ed2634d5c5699455.c1.e1" e2="3a2f058d14f4b6db1e7191a2ed2634d5c5699455.c1.e7" id="3a2f058d14f4b6db1e7191a2ed2634d5c5699455.c1.p7" relation="true"/>
    <pair e1="3a2f058d14f4b6db1e7191a2ed2634d5c5699455.c1.e2" e2="3a2f058d14f4b6db1e7191a2ed2634d5c5699455.c1.e3" id="3a2f058d14f4b6db1e7191a2ed2634d5c5699455.c1.p8" relation="true"/>
    <pair e1="3a2f058d14f4b6db1e7191a2ed2634d5c5699455.c1.e2" e2="3a2f058d14f4b6db1e7191a2ed2634d5c5699455.c1.e5" id="3a2f058d14f4b6db1e7191a2ed2634d5c5699455.c1.p9" relation="true"/>
    <pair e1="3a2f058d14f4b6db1e7191a2ed2634d5c5699455.c1.e2" e2="3a2f058d14f4b6db1e7191a2ed2634d5c5699455.c1.e6" id="3a2f058d14f4b6db1e7191a2ed2634d5c5699455.c1.p10" relation="true"/>
    <pair e1="3a2f058d14f4b6db1e7191a2ed2634d5c5699455.c1.e2" e2="3a2f058d14f4b6db1e7191a2ed2634d5c5699455.c1.e7" id="3a2f058d14f4b6db1e7191a2ed2634d5c5699455.c1.p11" relation="true"/>
    <pair e1="3a2f058d14f4b6db1e7191a2ed2634d5c5699455.c1.e3" e2="3a2f058d14f4b6db1e7191a2ed2634d5c5699455.c1.e4" id="3a2f058d14f4b6db1e7191a2ed2634d5c5699455.c1.p12" relation="true"/>
    <pair e1="3a2f058d14f4b6db1e7191a2ed2634d5c5699455.c1.e4" e2="3a2f058d14f4b6db1e7191a2ed2634d5c5699455.c1.e5" id="3a2f058d14f4b6db1e7191a2ed2634d5c5699455.c1.p13" relation="true"/>
    <pair e1="3a2f058d14f4b6db1e7191a2ed2634d5c5699455.c1.e4" e2="3a2f058d14f4b6db1e7191a2ed2634d5c5699455.c1.e6" id="3a2f058d14f4b6db1e7191a2ed2634d5c5699455.c1.p14" relation="true"/>
    <pair e1="3a2f058d14f4b6db1e7191a2ed2634d5c5699455.c1.e4" e2="3a2f058d14f4b6db1e7191a2ed2634d5c5699455.c1.e7" id="3a2f058d14f4b6db1e7191a2ed2634d5c5699455.c1.p15" relation="true"/>
  </chunk>
</document>
